Evaluate PGEN stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in PGEN? | Glauxie AI

Q: What are the risks of investing in PGEN?

Precigen, Inc. (PGEN) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Helen Sabzevari. Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for... Employees: 160.

Q: How much debt does PGEN have?

Review PGEN total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is PGEN a good long-term investment?

Evaluate PGEN as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in PGEN?

🦉

Precigen, Inc. (PGEN)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOHelen Sabzevari

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the...

Key Executives

Name	Title
Bryan T. Butman	Senior Vice President & Head of CMC
Donald Lehr	Chief Legal Officer & Corporate Secretary
Douglas E. Brough	Senior Vice President & Head of Research
Harry Thomasian Jr.	Chief Financial Officer
Helen Sabzevari	President, Chief Executive Officer & Director
Phil Tennant	Chief Commercial Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

PGEN Profile Financials

Is PGEN stock safe? How much debt does PGEN have? Is PGEN a good long-term investment?